SEPSIS & SEPTIC SHOCK 10.15. 2009

SEPSIS & SEPTIC SEPSIS & SEPTIC SHOCKSHOCK 10.15. 10.15. 2009 2009

Jaime Palomino, MDJaime Palomino, MDPulmonary & Critical Care MedicinePulmonary & Critical Care Medicine

Tulane University Health Sciences CenterTulane University Health Sciences CenterNew Orleans, LouisianaNew Orleans, Louisiana

EpidemiologyEpidemiology

Sepsis yearly incidence Sepsis yearly incidence 50 – 95 cases / 50 – 95 cases / 100,000100,000

Increasing by 9% each yearIncreasing by 9% each year 2% hospital admissions2% hospital admissions 9% sepsis 9% sepsis severe sepsis severe sepsis 3% severe sepsis 3% severe sepsis septic shock septic shock

10% of ICU admissions10% of ICU admissions

Annane D et al. Lancet 2005;365:63-78

Russell J. NEJM 2006;355:1699-713

Septic Shock – TreatmentSeptic Shock – Treatment

Initial Resuscitation Initial Resuscitation

Rivers E et al. NEJM 2001;345:1368-1377

What are the recommended vasopressors What are the recommended vasopressors in septic shock patients?in septic shock patients? MAP MAP ≥ 65 mmHg≥ 65 mmHg Norepinephrine and Dopamine Norepinephrine and Dopamine initial initial

vasopressors of choicevasopressors of choice Epinephrine Epinephrine first alternative when BP is first alternative when BP is

poorly responsive to Norepinephrine or poorly responsive to Norepinephrine or DopamineDopamine

VasopressorsVasopressors VasopressinVasopressin

• May be subsequently added to Norepinephrine May be subsequently added to Norepinephrine (Dose: 0.03units/min) with anticipation of an effect (Dose: 0.03units/min) with anticipation of an effect equivalent to Norepinephrine alone.equivalent to Norepinephrine alone.

Russell J et al. NEJM 2008;358:877-887

Povoa P et al. CCM 2009;37:410-416

VasopressorsVasopressors Comparison of Dopamine and Norepinephrine as the Comparison of Dopamine and Norepinephrine as the

First Vasopressor Agent in the Management of ShockFirst Vasopressor Agent in the Management of Shock De Backer D. NCT00314704De Backer D. NCT00314704 Primary Outcome Measures: 28 day survivalPrimary Outcome Measures: 28 day survival Estimated Enrollment: 1600 Estimated Enrollment: 1600 Study Start Date: December 2003 Study Start Date: December 2003 Estimated Study Completion Date: December 2010Estimated Study Completion Date: December 2010

SteroidsSteroids

Sprung et al. NEJM 2008;358:111-24

Relative Adrenal Insufficiency DiagnosisRelative Adrenal Insufficiency Diagnosis

Thomas Z et al. Ann Pharmacother 2007;41:1456-65

Dellinger R et al. Crit Care Med 2008; 36:296-327

Annane et al. JAMA 2009;301:2362-2375

Glucose ControlGlucose Control

Van Den Berghe G et al. NEJM 2001;345:1359-1367

Van Den Berghe G et al. NEJM 2006;354:449-461

Brunkhorst FM et al. NEJM 2008;358:125-139

NEJM 2009;360:1283-97

Septic Shock– TreatmentSeptic Shock– Treatment

Activated Protein CActivated Protein C

Bernard GR et al. NEJM 2001;344:699-709

Abraham E et al. NEJM 2005;353:1332-1341

Dellinger R et al. Crit Care Med 2008; 36:296-327

Early Versus Delayed Enteral Feeding and Omega-3 Fatty Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress SyndromeAcute Lung Injury or Acute Respiratory Distress Syndrome

(The EDEN-Omega Study) (The EDEN-Omega Study)

This study has been terminated. This study has been terminated. ( The Omega arm of this study was ( The Omega arm of this study was

stopped for futility. The EDEN arm stopped for futility. The EDEN arm continues to recruit patients as a separate continues to recruit patients as a separate independent study. )independent study. )

http://clinicaltrials.gov/ct2/show/study/NCT00609180

Early Versus Delayed Enteral Feeding and Omega-3 Fatty Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress SyndromeAcute Lung Injury or Acute Respiratory Distress Syndrome

(The EDEN-Omega Study) (The EDEN-Omega Study)

Interim analysis:Interim analysis: Mortality @ day 60:Mortality @ day 60:

• 26.6% Omega-3 Vs 16.3% Control26.6% Omega-3 Vs 16.3% Control Ventilator-Free days (within 28 days): Ventilator-Free days (within 28 days):

• 14.6 days Omega-3 Vs 17.4 days Control14.6 days Omega-3 Vs 17.4 days Control ICU-Free days (within 28 days):ICU-Free days (within 28 days):

• 13.9 days Omega-3 Vs 16.8 days Control13.9 days Omega-3 Vs 16.8 days Control

Chest Physician. August 2009. Elsevier.

Septic Shock – DiagnosisSeptic Shock – Diagnosis

Serum MarkersSerum Markers

Nobre V et al. AJRCCM 2008;177:498-505

Tang B et al. AJRCCM 2007;176:676-684

Wurfel M et al. AJRCCM 2008;178:710-720

Cinel I et al. CCM 2009;37:291-304

Russell J. NEJM 2006;355:1699-713

Last but not less important…Last but not less important… Sedation protocolSedation protocol

• Sedation GoalSedation Goal• Daily awakening trialsDaily awakening trials• Avoid NMBAs as much as possibleAvoid NMBAs as much as possible

DVT prophylaxisDVT prophylaxis Stress Ulcer (GI) prophylaxisStress Ulcer (GI) prophylaxis Consideration for Limitation of SupportConsideration for Limitation of Support

SEPSIS & SEPTIC SHOCK 10.15. 2009

Documents

Transcript of SEPSIS & SEPTIC SHOCK 10.15. 2009

Sepsis and septic shock guidelines

SEPSIS AND SEPTIC SHOCK - ASHNHA · Sepsis and Septic Shock Numerator Number of inpatient deaths in hospital due to severe sepsis with or without septic shock. Denominator Total number

SIRS SEPTIC SHOCK SEVERE SEPSIS MODS SPECIFY: SIRS Sepsis SEVERE Sepsis Septic Shock MODS (please specify EACH organ dysfunction and its link to sepsis.)

Severe Sepsis and Septic Shock - edisciplinas.usp.br

Sepsis and Septic Shock, 2008

°°°Severe Sepsis and Septic Shock- 2012

Sepsis and Septic Shocknicuvet.com/nicuvet/Equine-Perinatoloy/NICU... · •SIRS •Severe Sepsis •Septic Shock •MODS •ARDS •CARS. Septic Shock. Most common cause of death

Sepsis Septic Shock - National University

Surviving Sepsis Management of Severe Sepsis and Septic Shock

Severe Sepsis & Septic Shock. Severe sepsis + septic... · CEM Standards & Sepsis Six 27 ... Act, which focussed on the care of patients with sepsis. ... Severe Sepsis & Septic Shock

Severe Sepsis and Septic Shock - Rivers

Sepsis and Septic Shock

Epidemiology of Severe Sepsis and Septic Shock · Severe Sepsis and Septic Shock Understanding a Serious Killer 4 interchangeably: septicemia, sepsis, sepsis syndrome and septic shock.

Sepsis and Septic Shock...• Septic shock – sepsis induced hypotension persisting despite adequate fluid resuscitation –Sepsis induced hypotension – SBP

Antibiotic Recommendations for Sepsis and Septic Shock · Antibiotic Recommendations for Sepsis and Septic Shock • This guidance is for patients with sepsis and septic shock (Sepsis

Sepsis 3 Definitions, - CACCN · 1. Define sepsis and septic shock using the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). 2. Apply qSOFA and SOFA

Sepsis, Septic Shock, MODS

Sepsis: Epidemiology, Diagnosis, and Management - PACCM and septic shock.pdf · • Sepsis –SIRS + infection site • Severe sepsis –Sepsis with organ dysfunction • Septic Shock

Sepsis septic shock the lect

Managemet of sepsis and septic shock